These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9658075)

  • 1. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.
    Abe A; Chen ST; Miyanohara A; Friedmann T
    J Virol; 1998 Aug; 72(8):6356-61. PubMed ID: 9658075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells.
    Guibinga GH; Miyanohara A; Esko JD; Friedmann T
    Mol Ther; 2002 May; 5(5 Pt 1):538-46. PubMed ID: 11991744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection.
    Okimoto T; Friedmann T; Miyanohara A
    Mol Ther; 2001 Sep; 4(3):232-8. PubMed ID: 11545614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
    Ory DS; Neugeboren BA; Mulligan RC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11400-6. PubMed ID: 8876147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.
    Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW
    Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents.
    Sharma S; Murai F; Miyanohara A; Friedmann T
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10803-8. PubMed ID: 9380714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separable mechanisms of attachment and cell uptake during retrovirus infection.
    Sharma S; Miyanohara A; Friedmann T
    J Virol; 2000 Nov; 74(22):10790-5. PubMed ID: 11044124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer.
    Liu ML; Winther BL; Kay MA
    J Virol; 1996 Apr; 70(4):2497-502. PubMed ID: 8642678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
    Burns JC; Friedmann T; Driever W; Burrascano M; Yee JK
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8033-7. PubMed ID: 8396259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines.
    Arai T; Matsumoto K; Saitoh K; Ui M; Ito T; Murakami M; Kanegae Y; Saito I; Cosset FL; Takeuchi Y; Iba H
    J Virol; 1998 Feb; 72(2):1115-21. PubMed ID: 9445007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
    Emi N; Friedmann T; Yee JK
    J Virol; 1991 Mar; 65(3):1202-7. PubMed ID: 1847450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
    Johnson JE; Schnell MJ; Buonocore L; Rose JK
    J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
    Arai T; Takada M; Ui M; Iba H
    Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein.
    Mangor JT; Monsma SA; Johnson MC; Blissard GW
    J Virol; 2001 Mar; 75(6):2544-56. PubMed ID: 11222677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
    Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors.
    Li KJ; Garoff H
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11658-63. PubMed ID: 8876192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of high-titer pseudotyped retroviral vectors with very broad host range.
    Yee JK; Friedmann T; Burns JC
    Methods Cell Biol; 1994; 43 Pt A():99-112. PubMed ID: 7823872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype.
    Guibinga GH; Hall FL; Gordon EM; Ruoslahti E; Friedmann T
    Mol Ther; 2004 Jan; 9(1):76-84. PubMed ID: 14741780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.